PCR testing confirmed the presence of the BCR-ABL oncogene, and a bone marrow biopsy confirmed CML in the chronic phase, showing hypercellularity with prominent myelocytes and metamyelocytes. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.